Scalper1 News
First-quarter earnings reports and a correcting market have shaken up the industry group ranks. Here’s a look at some of the winners and losers for the week. The biotech group outperformed and recovered a portion of the prior week’s harsh losses. Group member Ligand Pharmaceuticals (LGND) is trading near a 79.71 buy point from a cup-with-handle base after finding support at its 50-day moving average. The stock broke out on April 8 in heavy volume Scalper1 News
Scalper1 News